The Oncology Institute receives Nasdaq bid price deficiency notice; stock below $1.00 for 30 days

Oncology Institute, Inc.

Nasdaq notice on June 20, 2024 for non-compliance with minimum bid price rule 5550(a)(2).
Common stock bid price below $1.00 per share for 30 consecutive business days.
180-day compliance period ends December 17, 2024; may get additional 180 days if eligible.
To regain compliance, bid price must close at $1.00+ for 10 consecutive business days.
Company will consider options including a reverse stock split, subject to stockholder approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.